|
|
||||||||
1 Laboratory of Public Health, Department of Environmental Veterinary Science, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan
2 Department of Pathology, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
3 Centre for Ecology and Hydrology, Oxford, UK
Correspondence
Takuya Iwasaki
tiwasaki{at}net.nagasaki-u.ac.jp
A stable full-length infectious cDNA clone of the Oshima strain of Tick-borne encephalitis virus (Far-Eastern subtype) was developed by a long high-fidelity RT-PCR and one-step cloning procedure. The infectious clone (O-IC) had four amino acid substitutions and produced smaller plaques when compared with the parent Oshima 5-10 strain. Using site-directed mutagenesis, the substitutions were reverted to restore the parent virus sequence (O-IC-pt). Although genetically identical, parent virus Oshima 5-10 and virus recovered from O-IC-pt demonstrated some biological differences that are possibly explained by the presence of quasispecies with differing virulence characteristics within the original virus population. These observations may have implications for vaccines based on modified infectious clones. It was also demonstrated that the amino acid substitution E-S40
P at position 40 in the envelope (E) glycoprotein was responsible for plaque size reduction, reduced infectious virus yields in cell culture and reduced mouse neurovirulence. Additionally, two amino acid substitutions in the non-structural (NS)5 protein (virus RNA-dependent RNA polymerase) NS5-V378
A and NS5-R674
K also contributed to attenuation of virulence in mice, but did not demonstrate a noticeable biological effect in baby hamster kidney cell culture. Comparative neurovirulence tests revealed how the accumulation of individual mutations (E-S40
P, NS5-V378
A and NS5-R674
K) can result in the attenuation of a virus.
This article has been cited by other articles:
![]() |
W. Fischl, S. Elshuber, S. Schrauf, and C. W. Mandl Changing the Protease Specificity for Activation of a Flavivirus, Tick-Borne Encephalitis Virus J. Virol., September 1, 2008; 82(17): 8272 - 8282. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhao, T. Date, Y. Li, T. Kato, M. Miyamoto, K. Yasui, and T. Wakita Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone J. Gen. Virol., August 1, 2005; 86(8): 2209 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. McElroy, K. A. Tsetsarkin, D. L. Vanlandingham, and S. Higgs Characterization of an infectious clone of the wild-type yellow fever virus Asibi strain that is able to infect and disseminate in mosquitoes J. Gen. Virol., June 1, 2005; 86(6): 1747 - 1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshii, A. Konno, A. Goto, J. Nio, M. Obara, T. Ueki, D. Hayasaka, T. Mizutani, H. Kariwa, and I. Takashima Single point mutation in tick-borne encephalitis virus prM protein induces a reduction of virus particle secretion J. Gen. Virol., October 1, 2004; 85(10): 3049 - 3058. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |